All Biomarkers Content

Bringing you the latest research in biomarker development, diagnostics, precision medicine and more through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Commentary
Looking at how Ultivue uses spatial imaging to observe biomarkers
10 March 2022
Biomarker Technologies
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a select group of like-minded experts on a monthly basis. Our first Biomarkers Discussion Group addressing ‘Implementing Flow Cytometry Assays In Biomarker Research’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
31 January 2022
Biomarker Technologies
Commentary
Liquid biopsy has the potential to become a transformative cancer management and therapeutic strategy within the next 5 to 10 years. However, its capability across all cancer stages largely depends upon assay sensitivity. In this commentary piece, the University of Edinburgh’s Tim Aitman takes us through a novel approach set to pioneer the landscape of liquid biopsy.
By Tia Byer |
01 December 2021
Biomarker Technologies
Insight Article
With an increasing need for large data analysis and validation, this Insight article takes an in-depth look at some of the recent advances in automation technologies affecting the flow cytometry field.
By Tia Byer |
08 November 2021
Biomarker Technologies
Commentary
How can the biomarkers industry best implement multi-parameter flow cytometry in clinical drug development? Vilma Decman of GlaxoSmithKline takes us through the advantages of using spectral flow cytometry, the importance of viability dyes, and high-parameter panel design.
By Tia Byer |
04 November 2021
Biomarker Technologies
Whitepaper
RNAscope™ technology from Advanced Cell Diagnostics (ACD), a Bio-Techne brand, enables RNA target expression analysis within intact cells and tissue with high sensitivity and specificity in both chromogenic and fluorescence assays.
22 October 2021
Biomarker Technologies
Video Content
Video Q&A
Moderated by: Wilco De Jager, Senior Field Applications Scientist, Luminex | Panellists: Brian McFarlin, Associate Professor, University of North Texas | John Nolan, Professor, Scintillon Institute | Sripad Ram, Senior Principal Scientist, Pfizer
17 March 2021
Biomarker Technologies
Video Content
Video Q&A
Video Interview: Zisis Koslakidis, Head, Laboratory Services & Biobanking, International Agency for Research on Cancer
25 February 2021
Biomarker Technologies
Written Q&A
Marti Jett, Chief Scientist (ST) Systems Biology, US Army Medical Research and Development Command
08 October 2019
Biomarker Technologies
Written Q&A
Thomas Misko, Lead Scientist & Senior Scientific Director, Translational Neuroscience, Abbvie Neuroscience Development
11 June 2019
Biomarker Technologies

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login